表紙
市場調查報告書

全球生物吸收性冠狀動脈支架市場分析與預測:品牌(Absorb BVS,第二世代Absorb,Magmaris,Magnitude,MeRes-100,DE Solve),各地區 2016年∼2025年

Bioresorbable Coronary Stents Market Analysis By Brand Outlook (Absorb BVS, Absorb 2nd Generation, Magmaris, Magnitude, MeRes-100, DESolve), By Region, And Segment Forecasts, 2016 - 2025

出版商 Grand View Research, Inc. 商品編碼 600822
出版日期 內容資訊 英文 77 Pages
商品交期: 2-3個工作天內
價格
Back to Top
全球生物吸收性冠狀動脈支架市場分析與預測:品牌(Absorb BVS,第二世代Absorb,Magmaris,Magnitude,MeRes-100,DE Solve),各地區 2016年∼2025年 Bioresorbable Coronary Stents Market Analysis By Brand Outlook (Absorb BVS, Absorb 2nd Generation, Magmaris, Magnitude, MeRes-100, DESolve), By Region, And Segment Forecasts, 2016 - 2025
出版日期: 2017年11月14日內容資訊: 英文 77 Pages
簡介

生物可吸收支架,吸收了之後,血管的功能以自然的形式恢復,主要用於年輕成人。全球生物可吸收支架市場,預計至2025年達2億4700萬美元的收入增加。

本報告提供全球生物吸收性冠狀動脈支架市場相關調查,市場概要,各品牌、地區的市場趨勢,市場規模的變化與預測,市場成長要素分析,市場佔有率,競爭情形,主要企業的簡介等,全面性資訊。

目錄

第1章 調查方法與範圍

  • 資訊採購
  • 調查方法
  • 市場預測與前提條件
  • 市場估計:各地區
  • 市場佔有率:各地區
  • 2次資訊來源的清單

第2章 摘要整理

  • 市場概要

第3章 全球生物吸收性冠狀動脈支架市場趨勢與範圍

  • 市場區隔和範圍
  • 滲透與成長預測製圖
  • SWOT分析
  • 產業分析 - 波特的五力分析

第4章 全球生物吸收性冠狀動脈支架市場趨勢分析與預測:各品牌

  • 品牌分析
  • 市場趨勢分析:各品牌

第5章 全球生物吸收性冠狀動脈支架市場趨勢分析與預測:各地區

  • 市場佔有率:各地區
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
  • 亞太地區
    • 日本
    • 印度

第6章 競爭情形

  • 策略架構
  • 參與企業的分類
  • 企業簡介

第7章 臨床實驗平台概要

  • Amaranth Medical
  • Microport Scientific Corporation
  • Arterius
目錄
Product Code: GVR-2-68038-234-1

Anticipated as well as recently launched global bioresorbable coronary stents market will trigger a revenue increase to USD 247 million by 2025. According to a new report by Grand View Research, Inc., better device attributes of second-generation coronary stents will provide the ascending push to this market.

Bioresorbable stents are intended majorly for the young adult population, whereby these individuals are enabled with a normal functioning artery following complete resorption of the dissolvable devices.Lifestyle diseases and prevalence of associated risk factors underpin the growth in atherosclerosis-related cardiac events. This drives the global disease prevalence in young adults as well as the high volume of elective Percutaneous Coronary Interventions (PCI).

What sets the second-generation bioresorbable coronary stents apart? - Learning from past mistakes, manufacturers have developed new generation bioresorbable with thinner strut thicknesses, faster resorption times, and better radial force. Amaranth, with a single-minded focus on strut thickness, has developed three such devices. Each with a thinner strut. The latest, Magnitude boasts of 100 microns.

Another factor providing a fillip to this market is the less-invasive nature of PCIs as compared to coronary artery bypass grafting, resulting in their high elective procedure volume. In most parts of the world, lack of auditing to check inappropriate surgeries drives the number of coronary stenting procedures. Hence, this market is expected to witness growth due to the high volume of elective PCI, particularly in APAC and Europe.

Further Key Findings From the Study Suggest:

  • Europe region is the major contributor for the bioresorbable stents market in 2016. Subsequent to withdrawal of the bioresorbable Absorb BVS, emergence of CE-approved bioresorbable stents hold strong growth prospects for greater sales in the member countries.
  • APAC follows Europe with almost 30% segment share and is expected to record the fastest growth in the future
  • Absorb BVS, among the key brands, engendered the highest sales revenue in 2016, while Absorb 2nd generation device will supersede the sales of its rival devices toward the end of the forecast period
  • North America trails behind as the smallest revenue generator against leading counterparts, Europe and APAC, in this market. Downfall of Abbott's Absorb BVS, the only approved FDA device, is the underlying reason for the small segment share in the U.S. region.
  • Key players in this space include BIOTRONIK, Meril Lifesciences Pvt. Ltd., Abbott, Elixir Medical Corporation, REVA Medical, Arterial Remodeling Technologies, and Amaranth Medical
  • Strategic efforts undertaken by the companies to gain a higher market share center on bioresorbable coronary stents development. Companies targeting the clinical pipeline have developed second-generation bioresorbable products with better design specifications, such as devices with thinner strut thicknesses and faster absorption rates that gain comparability with the gold standard, drug-eluting metallic stents.

Table of Contents

Chapter 1 Research Methodology & Scope

  • 1.1 Information Procurement
    • 1.1.1 Purchased database:
    • 1.1.2 GVR's internal database
  • 1.2 Research Methodology
  • 1.3 Geographic Scope & Assumptions
  • 1.4 Region-wise market calculation
    • 1.4.1 Region-wise market: Base estimates
    • 1.4.2 Global market: CAGR calculation
  • 1.5 Region-based Segment Share Calculation
  • 1.6 List of Secondary Sources

Chapter 2 Executive Summary

  • 2.1 Market Snapshot

Chapter 3 Bioresorbable Coronary Stents Market Variables, Trends & Scope

  • 3.1 Market Segmentation & Scope
    • 3.1.1 Market Driver Analysis
      • 3.1.1.1 High disease prevalence in young adults
      • 3.1.1.2 High Elective PCI Volume
    • 3.1.2 Market restraint analysis
      • 3.1.2.1 Slow pace of the market: Lack of adequate clinical trial results
      • 3.1.2.2 Low comparability of bioresorbable coronary stents to DES
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Bioresorbable Coronary Stents Market- SWOT Analysis, By Factor (political & legal, economic and technological)
  • 3.4 Industry Analysis - Porter's

Chapter 4 Bioresorbable Coronary Stents Market: Brand Outlook, Estimates & Trend Analysis

  • 4.1 Bioresorbable Coronary Stents Market: Brand analysis
  • 4.2 Bioresorbable Coronary Stents Market: Brand movement analysis
    • 4.2.1 Absorb BVS, 2016 - 2025 (USD Million)
    • 4.2.2 Absorb 2nd Generation, 2016 - 2025 (USD Million)
    • 4.2.3 Magmaris, 2016 - 2025 (USD Million)
    • 4.2.4 Magnitude, 2016 - 2025 (USD Million)
    • 4.2.5 MeRes-100, 2016 - 2025 (USD Million)
    • 4.2.6 DESolve, 2016 - 2025 (USD Million)

Chapter 5 Bioresorbable Coronary Stents Market: Regional Estimates & Trend Analysis

  • 5.1 Bioresorbable Coronary Stents Market share, by region, 2016 & 2024
  • 5.2 North America
    • 5.2.1 North America Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)
    • 5.2.2 U.S.
      • 5.2.2.1 U.S. Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)
    • 5.2.3 Canada
      • 5.2.3.1 Canada Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)
  • 5.3 Europe
    • 5.3.1 Europe Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)
    • 5.3.2 UK
      • 5.3.2.1 UK Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)
    • 5.3.3 Germany
      • 5.3.3.1 Germany Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)
    • 5.3.4 France
      • 5.3.4.1 France Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)
    • 5.3.5 Italy
      • 5.3.5.1 Italy Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)
    • 5.3.6 Spain
      • 5.3.6.1 Spain Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)
    • 5.4.2 Japan
      • 5.4.2.1 Japan Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)
    • 5.4.3 India
      • 5.4.3.1 India Bioresorbable Coronary Stents Market, 2016 - 2025 (USD Million)

Chapter 6 Competitive Landscape

  • 6.1 Strategy Framework
  • 6.2 Market Participation Categorization
  • 6.3 Company Profiles
    • 6.3.1 Biotronik
      • 6.3.1.1 Company overview
      • 6.3.1.2 Product overview
      • 6.3.1.3 Business Strategies
    • 6.3.2 Meril Lifesciences Pvt. Ltd.
      • 6.3.2.1 Company overview
      • 6.3.2.2 Product overview
      • 6.3.2.3 Business Strategies
    • 6.3.3 Abbott
      • 6.3.3.1 Company overview
      • 6.3.3.2 Product overview
      • 6.3.3.3 Business Strategies
    • 6.3.4 Elixir Medical Corporation
      • 6.3.4.1 Company overview
      • 6.3.4.2 Product overview
      • 6.3.4.3 Business Strategies
    • 6.3.5 REVA Medical
      • 6.3.5.1 Company overview
      • 6.3.5.2 Product overview
      • 6.3.5.3 Business Strategies
    • 6.3.6 Arterial Remodeling Technologies
      • 6.3.6.1 Company overview
      • 6.3.6.2 Product overview
      • 6.3.6.3 Business Strategies

Chapter 7 Clinical Pipeline Overview

  • 7.1 Amaranth Medical
    • 7.1.1 Company overview
    • 7.1.2 Pipeline products
    • 7.1.3 Clinical Trials
  • 7.2 Microport Scientific Corporation
    • 7.2.1 Company overview
    • 7.2.2 Pipeline products
    • 7.2.3 Clinical Trials
  • 7.3 Arterius
    • 7.3.1 Company overview
    • 7.3.2 Pipeline Products
    • 7.3.3 Clinical Trials

List of Tables

  • TABLE 1 Country share estimation
  • TABLE 2 North America bioresorbable coronary stents market estimates and forecasts, by brand outlook, 2016 - 2025 (USD Million)
  • TABLE 3 U.S bioresorbable coronary stents market estimates and forecasts, by brand outlook, 2016 - 2025 (USD Million)
  • TABLE 4 Canada bioresorbable coronary stents market estimates and forecasts, by brand outlook, 2016 - 2025 (USD Million)
  • TABLE 5 Europe bioresorbable coronary stents market estimates and forecasts, by brand outlook, 2016 - 2025 (USD Million)
  • TABLE 6 UK bioresorbable coronary stents market estimates and forecasts, by brand outlook, 2016 - 2025 (USD Million)
  • TABLE 7 Germany bioresorbable coronary stents market estimates and forecasts, by brand outlook, 2016 - 2025 (USD Million)
  • TABLE 8 Asia Pacific bioresorbable coronary stents market estimates and forecasts, by brand outlook, 2016 - 2025 (USD Million)
  • TABLE 9 Japan bioresorbable coronary stents market estimates and forecasts, by brand outlook, 2016 - 2025 (USD Million)
  • TABLE 10 India bioresorbable coronary stents market estimates and forecasts, by brand outlook, 2016 - 2025 (USD Million)
  • TABLE 11 List of Market Players

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Value chain-based sizing & forecasting
  • FIG. 4 QFD modeling for market share assessment
  • FIG. 5 Market summary
  • FIG. 6 Market trends & outlook
  • FIG. 7 Market segmentation & scope
  • FIG. 8 Market driver relevance analysis (Current & future impact)
  • FIG. 9 Global percentage of stroke occurrence, by age group
  • FIG. 10 Market restraint relevance analysis (Current & future impact)
  • FIG. 11 Penetration & growth prospect mapping
  • FIG. 12 SWOT Analysis, By Factor (political & legal, economic and technological)
  • FIG. 13 Porter's Five Forces Analysis
  • FIG. 14 Bioresorbable coronary stents market type outlook: key takeaways
  • FIG. 15 Bioresorbable coronary stents market: Type movement analysis
  • FIG. 16 Brand Outlook, 2016 - 2025 (USD Million)
  • FIG. 17 Regional market place: Key takeaways
  • FIG. 18 Regional outlook, 2016 & 2024
  • FIG. 19 North America bioresorbable coronary stents market, 2016 - 2025 (USD Million)
  • FIG. 20 U.S. bioresorbable coronary stents market, 2016 - 2025 (USD Million)
  • FIG. 21 Canada bioresorbable coronary stents market, 2016 - 2025 (USD Million)
  • FIG. 22 Europe bioresorbable coronary stents market, 2016 - 2025 (USD Million)
  • FIG. 23 UK bioresorbable coronary stents market, 2016 - 2025 (USD Million)
  • FIG. 24 Germany bioresorbable coronary stents market, 2016 - 2025 (USD Million)
  • FIG. 25 France bioresorbable coronary stents market, 2016 - 2025 (USD Million)
  • FIG. 26 Italy bioresorbable coronary stents market, 2016 - 2025 (USD Million)
  • FIG. 27 Spain bioresorbable coronary stents market, 2016 - 2025 (USD Million)
  • FIG. 28 Asia Pacific bioresorbable coronary stents market, 2016 - 2025 (USD Million)
  • FIG. 29 Japan bioresorbable coronary stents market, 2016 - 2025 (USD Million)
  • FIG. 30 India bioresorbable coronary stents market, 2016 - 2025 (USD Million)
  • FIG. 31 Strategy framework
  • FIG. 32 Participant categorization
Back to Top